Craneware (LSE:CRW) reported unaudited interim results for the six months ended 31 December 2025, highlighting steady revenue growth and improved profitability. Revenue increased 6% to $105.7 million, while adjusted EBITDA, profit before tax and earnings per share all recorded double-digit gains. Annual recurring revenue rose 4% to $184.2 million, with operating margins remaining above 30%. The company maintained a strong cash position, reduced bank debt and lifted its interim dividend by 11%, reflecting robust cash generation and balance sheet strength.
Operationally, Craneware continued to enhance its Trisus platform, including the development of advanced artificial intelligence capabilities in collaboration with Microsoft and the rollout of additional functionality planned for the second half of the year. The company also introduced what it described as the first fully integrated solution designed to address the evolving 340B rebate framework, despite the related pilot programme being postponed. Growth was supported by increased sales to new customers, net revenue retention of 103% and customer retention exceeding 90%. Management reinforced confidence in future performance with the announcement of a $25 million share buyback, signalling ambitions to further consolidate its position within the U.S. healthcare financial technology market.
Craneware’s outlook is underpinned by strong financial fundamentals, including healthy margins and a low-debt balance sheet. However, technical indicators remain weaker, with the share price trading below key moving averages and showing negative MACD momentum. Valuation metrics appear less supportive due to a relatively elevated price-to-earnings ratio, although dividend income provides some offset.
More about Craneware
Craneware plc is a UK-listed provider of healthcare financial performance software focused on hospitals and health systems in the United States. Through its Trisus cloud-based ecosystem, the company delivers revenue optimisation, analytics and 340B drug programme management tools designed to improve financial sustainability. A long-standing Microsoft partner, Craneware integrates proprietary data and AI technologies to help healthcare providers manage operational efficiency and regulatory complexity.
Leave a Reply